UPDATE : Monday, February 18, 2019
상단여백
Ministry OKs Peptron’s P2 clinical trial of Parkinson’s disease treatment by Lee Han-soo 2019-02-18 11:13
Sillajen’s research selected as cover paper for international journal by Lee Han-soo 2019-02-15 17:36
SK Biopharmaceuticals, Arvelle to develop, commercialize cenobamate in Europe by Lee Han-soo 2019-02-15 15:36
Acute myeloid leukemia treatment Rydapt approved as orphan drug by Lee Hye-seon 2019-02-15 15:36
Sanofi Genzyme Korea launches rare blood disorder franchise by Lee Han-soo 2019-02-15 14:37
라인
GC starts P2 trials of hepatitis B treatment by Lee Han-soo 2019-02-15 14:36
MSD leads rapidly growing antidiabetic DPP-4 inhibitors market by Kim Yun-mi 2019-02-15 14:31
Dong-A ST posts ₩567.2 billion in 2018 sales by Lee Han-soo 2019-02-14 16:13
Blood-thinning NOAC market expands 30% in 2018 by Kim Yun-mi 2019-02-14 12:12
Yuhan’s subsidiary wins ₩43.5 billion funding by Lee Han-soo 2019-02-13 17:04
라인
Price cut, expanded indication to prop up cholesterol-reducing PCSK9 inhibitors by Kim Yun-mi 2019-02-13 16:11
Mediforum gets ₩19 billion investment by Lee Han-soo 2019-02-13 15:19
Genexine, SCM Life Science acquire Argos Therapeutics by Lee Han-soo 2019-02-13 15:17
CJ Healthcare to export gastroesophageal reflux treatment to Latin America by Lee Han-soo 2019-02-13 10:50
GC posts ₩1.3 trillion in 2018 sales by Lee Han-soo 2019-02-13 10:50
라인
Bridge Biotherapeutics unveils clinical trials results for ulcerative colitis treatment by Lee Han-soo 2019-02-12 17:38
AbbVie’s new hepatitis C treatment outpaces Gilead’s rival drugs by Kim Yun-mi 2019-02-12 15:56
Pfizer Korea voluntarily recalls antibiotic Zyvox by Lee Hye-seon 2019-02-12 15:56
SK Chemical to co-promote Janssen’s dementia treatment by Lee Han-soo 2019-02-12 15:55
Demands for MMR vaccines spike amid resurgence of measles by Park Gi-taek 2019-02-12 11:19
여백
여백
여백
Back to Top